Exercise of Over-allotment Option

RNS Number : 9753N

Oxford Nanopore Technologies plc

04 October 2021

 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION WHERE SUCH DISTRIBUTION WOULD BE UNLAWFUL.  

Neither this announcement, nor anything contained herein, shall form the basis of, or be relied upon in connection with, any offer or commitment whatsoever in any jurisdiction. Investors should not subscribe for or purchase any shares referred to in this announcement except solely on the basis of the information contained in Oxford Nanopore Technologies plc's ("Oxford Nanopore" or the "Company" and, together with its subsidiaries, the "Group") prospectus dated 30 September 2021 (together with any supplementary prospectus, if relevant, the "Prospectus"), including the risk factors set out therein, that has been published by the Company in connection with the offer of ordinary shares in the Company (the "Shares") and the admission of such Shares to the standard listing segment of the Official List of the Financial Conduct Authority and to trading on the main market for listed securities of the London Stock Exchange plc. A copy of the Prospectus is available for inspection on the Company's website at https://nanoporetech.com/investors-update , subject to certain access restrictions.

4 October 2021

OXFORD NANOPORE TECHNOLOGIES PLC

Exercise of Over-allotment Option

Further to its announcement on 30 September 2021 relating to its initial public offering (the "Offer"), Oxford Nanopore Technologies plc (the "Company") announces that Citigroup Global Markets Limited, acting as stabilising manager, has today exercised in its entirety the over-allotment option granted by the Company (the "Over-allotment Option"), in respect of 18,501,661 ordinary shares in the Company at the offer price of 425 pence each.

From the exercise of the Over-allotment Option, the Company is expected to receive approximately £78.6 million in gross proceeds. Accordingly stabilisation will not be undertaken in connection with the Offer.

Giving effect to the exercise of the Over-allotment Option, the final size of the Offer is 141,846,069 ordinary shares, representing 17.44 per cent. of the Company's ordinary shares in issue, raising gross proceeds of approximately £602.8 million in aggregate.

Media Enquiries

[e-mail]

Tulchan Group (communications adviser to the Company)

Tom Murray, Olivia Peters, Deborah Roney

[phone]  [e-mail]

Important Legal Information

The information contained in this announcement is for background purposes only and does not purport to be full or complete, and this announcement does not constitute or form part of any invitation or inducement to engage in investment activity. No reliance may be placed by any person for any purpose on the information contained in this announcement or its accuracy, fairness or completeness.

This announcement is only addressed to and directed at specific addressees who: (A) if in member states of the European Economic Area (the "EEA"), are persons who are "qualified investors" within the meaning of Article 2(e) of Regulation (EU) 2017/1129 (as amended) ("Qualified Investors"); and (B) if in the United Kingdom, are "qualified investors" within the meaning of Article 2(e) of Regulation (EU) 2017/1129 (as amended) as it forms part of retained EU law by virtue of the European Union (Withdrawal) Act 2018 who are: (i) persons having professional experience in matters relating to investments who fall within the definition of "investment professionals" in Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the "Order"); or (ii) high net worth entities falling within Article 49(2)(a) to (d) of the Order; or (C) are other persons to whom it may otherwise lawfully be communicated (all such persons referred to in (B) and (C) together being "Relevant Persons"). This announcement must not be acted or relied on (i) in the United Kingdom, by persons who are not Relevant Persons and (ii) in any member state of the EEA by persons who are not Qualified Investors. Any investment activity to which this announcement relates (i) in the United Kingdom, is available only to, and may be engaged in only with, Relevant Persons; and (ii) in any member state of the EEA, is available only to, and may be engaged only with, Qualified Investors.

This announcement is not for publication or distribution, directly or indirectly, in or into the United States, Australia, Canada, Japan or South Africa or any other jurisdiction where to do so would constitute a violation of the relevant laws of such jurisdiction. The distribution of this announcement may be restricted by law in certain jurisdictions and persons into whose possession any document or other information referred to herein comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

This announcement is not an offer or solicitation to purchase or subscribe for, or otherwise invest in, securities, to any person in any jurisdiction, including the United States, Australia, Canada, Japan or South Africa, to whom or in which such offer or solicitation is unlawful. The securities referred to herein have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), or with any securities regulatory authority of any state or other jurisdiction of the United States. The securities may not be offered or sold in the United States, except pursuant to an applicable exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with any applicable securities laws of any state or other jurisdiction of the United States. No public offering of the securities referred to herein is being made in the United States, Australia, Canada, Japan or South Africa. Subject to certain exceptions, the Shares may not be offered or sold in Australia, Canada or Japan or to, or for the account or benefit of, any national, resident or citizen of Australia, Canada, Japan or South Africa. 

Nothing contained herein constitutes or should be construed as: (i) investment, tax, financial, accounting or legal advice; (ii) a representation that any investment or strategy is suitable or appropriate to your individual circumstances; or (iii) a personal recommendation to you.

Certain data in this announcement, including financial, statistical, and operating information has been rounded. As a result of the rounding, the totals of data presented in this announcement may vary slightly from the actual arithmetic totals of such data. Percentages may have been rounded and accordingly may not add up to 100%.

 

END

 

 

MSCFSUFMLEFSELS